Literature DB >> 9707550

Promoter-proximal stalling results from the inability to recruit transcription factor IIH to the transcription complex and is a regulated event.

K P Kumar1, S Akoulitchev, D Reinberg.   

Abstract

Promoter-proximal stalling, a general phenomenon observed during the expression of many RNA polymerase II transcribed genes, is dependent on transcription factor IIH (TFIIH). Reactions lacking TFIIH initiated transcription, but the transcription complex encountered a block to elongation proximal to the promoter. The accumulation of promoter-proximal stalled complexes was reduced in the presence of TFIIH and efficient escape from this site also required an activator. Promoter-proximal stalled complexes could not be induced to resume elongation. Our results indicate that effective recruitment of TFIIH into transcription complexes is achieved during formation of the preinitiation complex at the promoter. The studies establish that promoter clearance is a regulated event that requires TFIIH.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9707550      PMCID: PMC21411          DOI: 10.1073/pnas.95.17.9767

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  The RNA polymerase II ternary complex cleaves the nascent transcript in a 3'----5' direction in the presence of elongation factor SII.

Authors:  M G Izban; D S Luse
Journal:  Genes Dev       Date:  1992-07       Impact factor: 11.361

2.  The RNA polymerase II elongation complex. Factor-dependent transcription elongation involves nascent RNA cleavage.

Authors:  D Reines; P Ghanouni; Q Q Li; J Mote
Journal:  J Biol Chem       Date:  1992-08-05       Impact factor: 5.157

3.  Transcription initiation by RNA polymerase II in vitro. At least two nucleotides must be added to form a stable ternary complex.

Authors:  D S Luse; T Kochel; E D Kuempel; J A Coppola; H Cai
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

4.  Three transitions in the RNA polymerase II transcription complex during initiation.

Authors:  F C Holstege; U Fiedler; H T Timmers
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

5.  Elongation by Drosophila RNA polymerase II. Transcription of 3'-extended DNA templates.

Authors:  A E Sluder; D H Price; A L Greenleaf
Journal:  J Biol Chem       Date:  1988-07-15       Impact factor: 5.157

6.  Factors involved in specific transcription by mammalian RNA polymerase II. Transcription factor IIS stimulates elongation of RNA chains.

Authors:  D Reinberg; R G Roeder
Journal:  J Biol Chem       Date:  1987-03-05       Impact factor: 5.157

7.  Abortive initiation by RNA polymerase II in vitro at the adenovirus 2 major late promoter.

Authors:  D S Luse; G A Jacob
Journal:  J Biol Chem       Date:  1987-11-05       Impact factor: 5.157

Review 8.  The selectivity of transcription.

Authors:  M J Chamberlin
Journal:  Annu Rev Biochem       Date:  1974       Impact factor: 23.643

9.  A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.

Authors:  D L Bentley; M Groudine
Journal:  Nature       Date:  1986 Jun 12-18       Impact factor: 49.962

10.  Factors involved in specific transcription by mammalian RNA polymerase II. Factors IIE and IIF independently interact with RNA polymerase II.

Authors:  O Flores; E Maldonado; D Reinberg
Journal:  J Biol Chem       Date:  1989-05-25       Impact factor: 5.157

View more
  26 in total

1.  The general transcription factors IIA, IIB, IIF, and IIE are required for RNA polymerase II transcription from the human U1 small nuclear RNA promoter.

Authors:  T C Kuhlman; H Cho; D Reinberg; N Hernandez
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

2.  Discrete promoter elements affect specific properties of RNA polymerase II transcription complexes.

Authors:  J W Steinke; S J Kopytek; D O Peterson
Journal:  Nucleic Acids Res       Date:  2000-07-15       Impact factor: 16.971

3.  Spt5 cooperates with human immunodeficiency virus type 1 Tat by preventing premature RNA release at terminator sequences.

Authors:  Cyril F Bourgeois; Young Kyeung Kim; Mark J Churcher; Michelle J West; Jonathan Karn
Journal:  Mol Cell Biol       Date:  2002-02       Impact factor: 4.272

4.  Analysis of the open region of RNA polymerase II transcription complexes in the early phase of elongation.

Authors:  U Fiedler; H T Timmers
Journal:  Nucleic Acids Res       Date:  2001-07-01       Impact factor: 16.971

5.  Promoter clearance by RNA polymerase II is an extended, multistep process strongly affected by sequence.

Authors:  M Pal; D McKean; D S Luse
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

6.  Ubiquitination of RNA polymerase II large subunit signaled by phosphorylation of carboxyl-terminal domain.

Authors:  A Mitsui; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

7.  An 8 nt RNA triggers a rate-limiting shift of RNA polymerase II complexes into elongation.

Authors:  Aaron R Hieb; Sean Baran; James A Goodrich; Jennifer F Kugel
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

8.  TFIIA plays a role in the response to oxidative stress.

Authors:  Susan M Kraemer; David A Goldstrohm; Ann Berger; Susan Hankey; Sherry A Rovinsky; W Scott Moye-Rowley; Laurie A Stargell
Journal:  Eukaryot Cell       Date:  2006-07

9.  A role for Chk1 in blocking transcriptional elongation of p21 RNA during the S-phase checkpoint.

Authors:  Rachel Beckerman; Aaron J Donner; Melissa Mattia; Melissa J Peart; James L Manley; Joaquin M Espinosa; Carol Prives
Journal:  Genes Dev       Date:  2009-06-01       Impact factor: 11.361

10.  The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription.

Authors:  Takeshi Shimi; Katrin Pfleghaar; Shin-ichiro Kojima; Chan-Gi Pack; Irina Solovei; Anne E Goldman; Stephen A Adam; Dale K Shumaker; Masataka Kinjo; Thomas Cremer; Robert D Goldman
Journal:  Genes Dev       Date:  2008-12-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.